The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue
about
sameAs
Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinomaMetabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview.Steroidogenesis in the skin: implications for local immune functionsScreening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety EvaluationAlcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening TrialCellular and molecular mechanisms underlying alcohol-induced aggressiveness of breast cancerHuman pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alphaUpdate information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.Key role of CRF in the skin stress response system.CYP2B6*6 is associated with increased breast cancer risk.Collagen density regulates xenobiotic and hypoxic response of mammary epithelial cellsGene expression profiling of breast cancer cell lines in response to soy isoflavones using a pangenomic microarray approach.The role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patientsPharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer managementCYP4B1: an enigmatic P450 at the interface between xenobiotic and endobiotic metabolism.Non-nutritive sweeteners in breast milk: perspective on potential implications of recent findings.Pharmacogenetics and oncology treatment for breast cancer.Drug metabolism by tumours: its nature, relevance and therapeutic implications.Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women.Pharmacogenetics of chemotherapy efficacy in breast cancer.Toxicogenetic profile and cancer risk in Lebanese.The red wine polyphenol resveratrol reduces polycyclic aromatic hydrocarbon-induced DNA damage in MCF-10A cells.Genistein protects against polycyclic aromatic hydrocarbon-induced oxidative DNA damage in non-cancerous breast cells MCF-10A.PPARalpha and PPARbeta are differentially affected by ethanol and the ethanol metabolite acetaldehyde in the MCF-7 breast cancer cell line.Biotransformation of melatonin in human breast cancer cell lines: role of sulfotransferase 1A1.A potential protective mechanism of soya isoflavones against 7,12-dimethylbenz[a]anthracene tumour initiation.Tracing metabolite profiles in human milk: studies on the odorant 1,8-cineole transferred into breast milk after oral intake
P2860
Q24795015-62C96600-A551-448D-9EB9-DB1FBFC7A95BQ24796091-976499AC-8FA3-477F-9DB3-361F7C6C037DQ26830355-A3F2611E-DED3-43CF-A03F-D92675904BCEQ26860299-C196710C-D651-4661-9F73-5C8357A57E0EQ28395003-A8EC1F9D-0000-4D52-90F4-BA68B31EFC68Q28397579-425C4F3F-AFDA-441A-9FED-844D5DE30F54Q33345012-95F08BCF-AD03-4542-AFF0-060E0C5FBE1EQ34204238-254284C9-3AEF-4098-ADB8-9A64A0AF8066Q34363640-EF76E765-07B3-44ED-A577-5274AE638B2FQ34793437-D7AE9BB4-7AFF-4465-9F61-4502FD71C9FAQ35071054-AD846367-AF87-4159-BA84-65C4F65868F1Q35082728-F822C209-BB05-4F46-AE42-EAD2537D175CQ36154045-D66D684D-7CEC-44D4-9328-0C2BD123DD14Q36441485-4CE373E6-AD77-421E-8BFC-77069B661A32Q36551130-43EA6118-D30A-489A-86D9-D7FEC7B37DB0Q36568181-A4DC6826-732C-44CD-8899-14EA984E83B6Q36719659-2B45C598-47AD-4D12-8C95-366EB2D93B74Q37008879-C4A866D5-C507-4E62-9B56-D5914727C56AQ37360198-A1BA46C4-849C-41C8-8E89-8ADF3A4E9F59Q38003703-299A2A8E-E111-4F56-A87F-153901DEB14AQ38195853-6B8A052A-99BF-43BB-AADA-EC0BB95A7E6DQ39790303-FC8A6330-12E2-40C7-A255-B0C935FF02B5Q39969691-1A2FA390-3D59-4106-8495-135D1D4FEEB9Q40051979-B66E9DCD-4A72-4224-8347-0347B06E928CQ40376028-8BF3A229-46CE-4171-AE9D-6A9FC523A17DQ44543217-1CFD71F6-4191-41A8-9D09-5593591D32A5Q57889075-CF11199D-2800-46EC-B1AC-654372159538
P2860
The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue
description
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im November 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: November 2001)
@en
vedecký článok (publikovaný 2001-11)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd in 2001-11)
@nl
наукова стаття, опублікована в листопаді 2001
@uk
مقالة علمية (نشرت في نوفمبر 2001)
@ar
name
The expression of cytochrome P ...... mours and normal breast tissue
@ast
The expression of cytochrome P ...... mours and normal breast tissue
@en
The expression of cytochrome P ...... mours and normal breast tissue
@nl
type
label
The expression of cytochrome P ...... mours and normal breast tissue
@ast
The expression of cytochrome P ...... mours and normal breast tissue
@en
The expression of cytochrome P ...... mours and normal breast tissue
@nl
prefLabel
The expression of cytochrome P ...... mours and normal breast tissue
@ast
The expression of cytochrome P ...... mours and normal breast tissue
@en
The expression of cytochrome P ...... mours and normal breast tissue
@nl
P2093
P2860
P356
P1476
The expression of cytochrome P ...... mours and normal breast tissue
@en
P2093
P2860
P2888
P356
10.1023/A:1012526406741
P407
P577
2001-11-01T00:00:00Z
P6179
1003575049